Atlas Trials

Neoadjuvant Immunotherapy With Chemotherapy for Stage I-IIIB Non-Small Cell Lung Cancer Patients

Clinical trial NCT04941417 · UNKNOWN

Trial details

NCT number
NCT04941417
Sponsor
Peking Union Medical College
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2020-11-24
Primary completion
2023-06-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.